EM-T3Expert Opinion on Drug Safety2024-04-29第 24 卷第 1 期,111-119
Evaluation of the safety and efficacy of biosimilar recombinant growth hormone in children with growth hormone deficiency: non-inferiority, randomized, parallel, multicentric and Phase III trial